2026 ICD-10-CM Diagnosis Code Z16.13Resistance to carbapenem

ICD-10-CM Codes›Z00–Z99›Z16›Z16

ICD-10-CM Z16.13
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

Z16.13 is a billable ICD-10-CM diagnosis code for resistance to carbapenem. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 867 through 869. The code is not accepted as a principal diagnosis by the Medicare Code Editor. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Resistance to antimicrobial drugs.

Code Identity

ICD-10-CM Code
Z16.13
Billable Status
Yes — Valid for Submission
Code Describes
Resistance to carbapenem
Short Description
Resistance to carbapenem
Same as the full description in the CMS dataset.
Parent Code
Z16.1
Resistance to beta lactam antibiotics

Code Classification

ChapterZ00–Z99Factors influencing health status and contact with health services
SectionZ16Resistance to antimicrobial drugs
CategoryZ16Resistance to antimicrobial drugs
This CodeZ16.13Resistance to carbapenem

Code EditsBilling

Medicare Code Editor checks that affect claim validity for Z16.13.

Unacceptable principal diagnosis
There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Resistance, resistant(to)
      • organism (s)
        • to
          • drug
            • carbapenem

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR FAC015
Resistance to antimicrobial drugs
Default principal diagnosis: inpatient No · outpatient Yes

Code History & ChangesHistory

Replacement Z16.13 replaces the following previously assigned code(s):

  • Z16.19 - Resistance to other specified beta lactam antibiotics
FY 2024AddedAdded to the ICD-10-CM code setEffective October 1, 2023.
FY 2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About Z16.13Overview

Is Z16.13 (Resistance to beta lactam antibiotics) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report resistance to carbapenem on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does Z16.13 group to?

On inpatient claims, resistance to carbapenem maps to MS-DRG 867, 868, 869, with relative weights from 0.7297 to 2.0932 depending on complications. Higher weights mean higher Medicare reimbursement.

Can Z16.13 be a principal diagnosis?

No. The Medicare Code Editor rejects this code as a principal diagnosis because resistance to carbapenem describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.